0001104659-21-119309.txt : 20210924 0001104659-21-119309.hdr.sgml : 20210924 20210924162111 ACCESSION NUMBER: 0001104659-21-119309 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210923 FILED AS OF DATE: 20210924 DATE AS OF CHANGE: 20210924 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LAPOINTE ANTHONY GREGG CENTRAL INDEX KEY: 0001331860 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14778 FILM NUMBER: 211277570 MAIL ADDRESS: STREET 1: PO BOX 83216 CITY: GAITHERSBURG STATE: MD ZIP: 20883-3216 FORMER NAME: FORMER CONFORMED NAME: Lapointe Gregg Anthony DATE OF NAME CHANGE: 20050630 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SOLIGENIX, INC. CENTRAL INDEX KEY: 0000812796 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 411505029 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE B-10 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 609-538-8200 MAIL ADDRESS: STREET 1: 29 EMMONS DRIVE STREET 2: SUITE B-10 CITY: PRINCETON STATE: NJ ZIP: 08540 FORMER COMPANY: FORMER CONFORMED NAME: DOR BIOPHARMA INC DATE OF NAME CHANGE: 20020329 FORMER COMPANY: FORMER CONFORMED NAME: ENDOREX CORP DATE OF NAME CHANGE: 19960916 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC DATE OF NAME CHANGE: 19920703 4 1 tm2128426-2_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2021-09-23 0 0000812796 SOLIGENIX, INC. SNGX 0001331860 LAPOINTE ANTHONY GREGG 29 EMMONS DRIVE, SUITE B-10 PRINCETON NJ 08540 1 0 0 0 Stock Option (Right to Buy) 1.03 2021-09-23 4 A 0 29126 0 A 2031-09-22 Common Stock 29126 29126 D The stock option vests ratably on each of December 23, 2021, March 23, 2022, June 23, 2022 and September 23, 2022. /s/ Gregg A. Lapointe 2021-09-24